138 related articles for article (PubMed ID: 24795288)
1. Timing of income assistance payment and overdose patterns at a Canadian supervised injection facility.
Zlotorzynska M; Milloy MJ; Richardson L; Nguyen P; Montaner JS; Wood E; Kerr T
Int J Drug Policy; 2014 Jul; 25(4):736-9. PubMed ID: 24795288
[No Abstract] [Full Text] [Related]
2. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
Notta D; Black B; Chu T; Joe R; Lysyshyn M
Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
[TBL] [Abstract][Full Text] [Related]
3. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.
Kerr T; Stoltz JA; Tyndall M; Li K; Zhang R; Montaner J; Wood E
BMJ; 2006 Jan; 332(7535):220-2. PubMed ID: 16439401
[TBL] [Abstract][Full Text] [Related]
4. Is Vancouver Canada's supervised injection facility cost-saving?
Pinkerton SD
Addiction; 2010 Aug; 105(8):1429-36. PubMed ID: 20653622
[TBL] [Abstract][Full Text] [Related]
5. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
Jozaghi E
Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
[No Abstract] [Full Text] [Related]
6. Safe injection facilities save lives.
Beyrer C
Lancet; 2011 Apr; 377(9775):1385-6. PubMed ID: 21497899
[No Abstract] [Full Text] [Related]
7. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T
Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898
[TBL] [Abstract][Full Text] [Related]
8. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
Andresen MA; Boyd N
Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
[TBL] [Abstract][Full Text] [Related]
9. Supervised injection services: what has been demonstrated? A systematic literature review.
Potier C; Laprévote V; Dubois-Arber F; Cottencin O; Rolland B
Drug Alcohol Depend; 2014 Dec; 145():48-68. PubMed ID: 25456324
[TBL] [Abstract][Full Text] [Related]
10. The lessons learned from the fentanyl overdose crises in British Columbia, Canada.
Thomson E; Lampkin H; Maynard R; Karamouzian M; Jozaghi E
Addiction; 2017 Nov; 112(11):2068-2070. PubMed ID: 28901045
[No Abstract] [Full Text] [Related]
11. [The initial experience in supervised injecting facilities in Denmark].
Axelsson A; Hvam F; Bonde M; Olsen ML; Kiørboe E; Hoff-Lund O; Abildgaard M; Iversen K
Ugeskr Laeger; 2012 Sep; 174(39):2286-9. PubMed ID: 23006221
[TBL] [Abstract][Full Text] [Related]
12. Decline in needle exchange use in Vancouver, Canada coincides with the Australian heroin shortage.
Small W; Wood E; Buchner C; Fair B; Kerr T
Int J Drug Policy; 2008 Aug; 19(4):291-2; discussion 295-6. PubMed ID: 18424114
[No Abstract] [Full Text] [Related]
13. Ireland is to install supervised injecting rooms.
Houston M
BMJ; 2016 Jan; 532():i406. PubMed ID: 26801053
[No Abstract] [Full Text] [Related]
14. Vancouver's supervised injection facility challenges Canada's drug laws.
Dooling K; Rachlis M
CMAJ; 2010 Sep; 182(13):1440-4. PubMed ID: 20805208
[No Abstract] [Full Text] [Related]
15. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation.
Sergeev B; Karpets A; Sarang A; Tikhonov M
J Urban Health; 2003 Jun; 80(2):212-9. PubMed ID: 12791797
[TBL] [Abstract][Full Text] [Related]
16. Opening Canada's first Health Canada-approved supervised consumption sites.
Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs.
Kuyper LM; Kerr T; Li K; Hogg RS; Tyndall MW; Montaner JS; Wood E
Subst Use Misuse; 2006; 41(6-7):883-99. PubMed ID: 16809177
[TBL] [Abstract][Full Text] [Related]
18. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
Wallace B; Pagan F; Pauly BB
Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
[TBL] [Abstract][Full Text] [Related]
19. Harm reduction and needle exchange programmes.
Bluthenthal RN; Kral AH; Lorvick J; Erringer EA; Edlin BR
Lancet; 1998 Jun; 351(9118):1819-20. PubMed ID: 9635989
[No Abstract] [Full Text] [Related]
20. Characterizing Use of Supervised Consumption Services among Street-involved Youth and Young Adults in the Context of an Overdose Crisis.
Lee-Pii K; DeBeck K; Choi J; Sedgemore KO; Kerr T; Kennedy MC
J Urban Health; 2024 Apr; 101(2):233-244. PubMed ID: 38536600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]